NCT01769937View on ClinicalTrials.gov

Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Lupus Erythematosus Systemic Exacerbation
Interventions
DRUG

H.P. Acthar Gel

Open-label H.P. Acthar Gel given subcutaneous injection once daily for 10 days with potential for additional 5 days of dosing

Trial Locations (1)

48910

Justus J. Fiechtner, Lansing

All Listed Sponsors
lead

Fiechtner, Justus J., M.D., P.C.

INDIV

NCT01769937 - Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter